Arrhythmias in Former Elite Athletes

Study Questions:

How does the prevalence of atrial fibrillation (AF) in former National Football League (NFL) athletes compare to population-based controls, and is there a difference in conduction system abnormalities?

Methods:

This was a cross-sectional study comparing a self-selected sample of former NFL players to a population-based nonelite athlete group of similar age and racial composition from the Dallas Heart Study-2. Univariable and multivariable logistic regression models were used to assess the association of baseline covariates with AF. Given baseline differences between NFL participants and Dallas Heart Study-2 participants, propensity score matching was employed.

Results:

There were 460 former NFL athletes (mean age 56 years, 47% black) and 925 Dallas Heart Study-2 participants (mean age 54 years, 53% black). AF was present in 28 individuals (n = 23 [5%] in the NFL group; n = 5 [0.5%] in the control group). After controlling for other cardiovascular risk factors in multivariable regression analysis, former NFL participation remained associated with a 5.7 (95% confidence interval, 2.1–15.9, p < 0.001) higher odds ratio of AF. AF was previously undiagnosed in 15/23 of the former NFL players. Previously undiagnosed NFL players were rate controlled and asymptomatic, but 80% had a CHA2DS2-VASc score ≥1. Former NFL players also had an eightfold higher prevalence of paced cardiac rhythms (2.0% vs. 0.25%, p < 0.01). Former NFL athletes had lower resting heart rates (62 ± 11 vs. 66 ± 11 bpm, p < 0.001), and a higher prevalence of first-degree atrioventricular block (18% vs. 9%, p < 0.001).

Conclusions:

Former NFL participation was associated with an increased AF prevalence and slowed cardiac conduction when compared with a population-based control group. Former NFL athletes who screened positive for AF were generally rate controlled and asymptomatic, but 80% should have been considered for anticoagulation based on their stroke risk.

Perspective:

Benefits of regular moderate exercise are well established. Strenuous endurance exercise has previously been shown in a number of studies to be associated with greater risk of AF, but the current study suggests that this increased risk is also applicable to strength-type exercise. In this cross-sectional cohort, former NFL players had an almost sixfold increase in the risk of AF than controls, despite lower rates of traditional risk factors for AF, such as smoking, hypertension, hyperlipidemia, and diabetes mellitus. The majority of new cases of AF identified during screening were asymptomatic, perhaps in part due to exercise-induced alterations in autonomic tone and slower atrioventricular nodal conduction. It is not clear whether those alterations persist after the athletic activity abates. The report does not provide any insight into the ongoing activity level in the former NFL players. The main implications of this study are the need for heightened AF surveillance in the former NFL players given their asymptomatic status and CHA2DS2-VASc scores, which place them in the stroke prevention category. The current study should be considered in the context of a recent NFL survival study, which showed that overall all-cause mortality and cardiovascular mortality were lower among former NFL players than in the general population, except when playing-time body mass index of the NFL players exceeded >35 kg/m2.

Keywords: Anticoagulants, Arrhythmias, Cardiac, Athletes, Atrial Fibrillation, Atrioventricular Block, Exercise, Football, Heart Conduction System, Heart Failure, Risk Factors, Secondary Prevention, Sports, Stroke, Vascular Diseases


< Back to Listings